Japanese Journal of Clinical Oncology Advance Access published online on September 28, 2006
Japanese Journal of Clinical Oncology, doi:10.1093/jjco/hyl098
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Department of Radiation Oncology, Chung Shan Medical University Hospital, Taichung, Taiwan; Institute of Medicine & Toxicology, Chung Shan Medical University Hospital, Taichung, Taiwan
* To whom correspondence should be addressed. Background: To evaluate the factors influencing post-irradiation parotid gland function in nasopharyngeal cancer treated with parotid-sparing radiotherapy. Methods: This study consisted of 45 patients with nasopharyngeal cancer treated with radiotherapy including 3D conformal radiotherapy, intensity-modulated radiotherapy and high-dose-rate brachytherapy. The mean follow-up time was 37.5 months (range: 15-50 months). Objective parotid gland function was assessed by series sialoscintigraphy pre-irradiation and post-irradiation at 1, 6, 12 and 18 months. Subjective salivary function was recorded by the LENT/SOMA system. Wilcoxon signed-rank test was used to compare the secretion ratio (SR) of parotid gland before and after treatment. Mann-Whitney rank-sum test was used to determine the factors influencing the post-irradiated SR. Chi-square test was used to compare the correlation between subjective grading of xerostomia and objective grading of parotid glands. Results: There was a significant difference between the pre-irradiation and post-irradiation parotid gland's SR at 1 (0.30 versus 0.01, P < 0.05) and 6 months (0.03 versus 0.08, P < 0.05). However, there was no significant difference compared with the pre-irradiation SR at 12 (0.30 versus 0.20, P > 0.05) and 18 months (0.30 versus 0.18, P > 0.05). There was significant correlation between subjective and objective salivary function (P = 0.024) at 12 months after radiotherapy. The factor that impacted the preservation of parotid function was mean dose to the parotid gland >38.0 Gy (P < 0.05). Conclusions: Our results demonstrated that parotid function could recover 1 year after treatment with parotid-sparing radiotherapy in patients with nasopharyngeal cancer. The most important factor that influenced parotid function was the mean dose to the parotid gland.
Received April 16, 2006
Accepted August 11, 2006
Original Article
Factors Influencing the Parotid Function in Nasopharyngeal Carcinoma Treated with Parotid-Sparing Radiotherapy
Wen-Shan Liu 1 *, Steve Pai-Hsun Lee 2, Jong-Kang Lee 3, Mao-Chang Su 4, Gin-Den Chen 5, Hong-Shen Lee 6, and Huei Lee 7
2 Department of Radiation Oncology, University of California, Los Angeles, USA
3 Department of Nuclear Medicine, Chung Shan Medical University Hospital, Taichung, Taiwan
4 Department of Otolaryngology, Chung Shan Medical University Hospital, Taichung, Taiwan
5 Institue of Medicine, Chung Shan Medical University Hospital, Taichung, Taiwan
6 Institue of Public Health, Chung Shan Medical University, Taichung, Taiwan
7 Institute of Medicine & Toxicology, Chung Shan Medical University Hospital, Taichung, Taiwan
Wen-Shan Liu, E-mail: p53_tw{at}yahoo.com.tw
![]()
Abstract ![]()
CiteULike
Connotea
Del.icio.us What's this?